Regencell Bioscience Holdings Ltd
RGC215.500USD
+25.509+13.43%
Market hours （ET）Quotes delayed by 15 min
2.80BMarket Cap
--P/E TTM
More Details of Regencell Bioscience Holdings Ltd Company
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Company Info
Company codeRGC
Company nameRegencell Bioscience Holdings Ltd
IPO dateJul 16, 2021
Founded at2014
CEO- -
Number of employees12
Security typeOrdinary Share
Fiscal year-endJul 16
Address11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
City
Stock exchangeNASDAQ Capital Market Consolidated
CountryHong Kong
Postal code- -
Phone85221550823
Websitehttps://www.regencellbioscience.com/
Company codeRGC
IPO dateJul 16, 2021
Founded at2014
Company Executives
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Sun, May 4
Update time: Sun, May 4
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Au (Yat-Gai)
86.24%
Digital Mobile Venture, Ltd.
7.60%
UBS Financial Services, Inc.
0.22%
Geode Capital Management, L.L.C.
0.05%
Morgan Stanley & Co. LLC
0.02%
Other
5.87%
Shareholder Statistics
Shareholder
Proportion
Au (Yat-Gai)
86.24%
Digital Mobile Venture, Ltd.
7.60%
UBS Financial Services, Inc.
0.22%
Geode Capital Management, L.L.C.
0.05%
Morgan Stanley & Co. LLC
0.02%
Other
5.87%
Type
Shareholder
Proportion
Individual Investor
86.24%
Corporation
7.60%
Investment Advisor
0.23%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.02%
Other
5.87%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
11
12.25M
94.13%
+666.12K
2024Q4
10
11.60M
89.11%
+20.25K
2024Q3
10
11.58M
89.01%
+24.37K
2024Q2
11
11.57M
88.87%
+5.63K
2024Q1
12
11.56M
88.83%
-17.42K
2023Q4
12
11.57M
88.94%
+13.30K
2023Q3
13
11.56M
88.82%
-12.42K
2023Q2
13
11.55M
88.77%
-36.88K
2023Q1
12
11.55M
88.79%
+958.07K
2022Q4
12
11.55M
88.80%
+958.33K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Au (Yat-Gai)
11.22M
86.24%
+652.98K
+6.18%
Mar 10, 2025
Digital Mobile Venture, Ltd.
988.90K
7.6%
--
--
Jun 30, 2024
UBS Financial Services, Inc.
29.22K
0.22%
+11.34K
+63.45%
Dec 31, 2024
Geode Capital Management, L.L.C.
6.82K
0.05%
--
--
Feb 28, 2025
Morgan Stanley & Co. LLC
2.10K
0.02%
+2.10K
--
Dec 31, 2024
BlackRock Financial Management, Inc.
238.00
0%
--
--
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
5.00
0%
-10.00
-66.67%
Jan 31, 2024
Qube Research & Technologies Ltd
--
0%
-13.00
-100.00%
Sep 30, 2024
Morgan Stanley Smith Barney LLC
--
0%
-326.00
-100.00%
Dec 31, 2023
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data